Qyuns Therapeutics recently announced an exclusive global cooperation and licensing deal with F. Hoffmann La Roche Ltd (Roche) for its self-developed long-acting dual antibody, QX031N injection.
China will take the initiative to open its market wider during the 15th Five-Year Plan period (2026-30), Commerce Minister Wang Wentao said at a news conference on Friday.
China has unveiled the major objectives for the 15th Five-Year Plan (2026-30) period, outlining a clear roadmap for the nation's next phase of development.
At Nestlé Health Science China's production workshop, a batch of Isosource@ series full nutrition formula special medical food is about to be shipped to European countries.
This year marks the conclusion of China's 14th Five-Year Plan (2021-25), a period during which the country has made significant strides in achieving its economic and social development goals.
Taizhou has moved to further boost its cooperation with the world's leading intergovernmental organization for research, training and technology transfer.